Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
JAMA
|
February 14, 2022
Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance
Amadea Britton, Katherine E Fleming-Dutra, Nong Shang, et al.
Vaccine
|
July 2, 2022
Methodology for a correlate of protection for group B Streptococcus: Report from the Bill & Melinda Gates Foundation workshop held on 10 and 11 February 2021
Peter B Gilbert, Richard Isbrucker, Nick Andrews, et al.
JAMA Pediatrics
|
January 13, 2015
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid
M Elsa Villarino, Nigel A Scott, Stephen E Weis, et al.
JAMA Internal Medicine
|
December 5, 2022
Association of Pneumococcal Conjugate Vaccine Use With Hospitalized Pneumonia in Medicare Beneficiaries 65 Years or Older With and Without Medical Conditions, 2014 to 2017
Miwako Kobayashi, Michael W Spiller, Xiyuan Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 7, 2007
Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays
Gerald H Mazurek, Margan J Zajdowicz, Arlene L Hankinson, et al.
Open Forum Infectious Diseases
|
May 22, 2023
Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods
Allison Avrich Ciesla, Ryan E Wiegand, Zachary R Smith, et al.
The Journal of Infectious Diseases
|
September 1, 2021
Nasopharyngeal Carriage of Streptococcus pneumoniae Among Young Children in Haiti Before Pneumococcal Conjugate Vaccine Introduction
Louise K Francois Watkins, Jennifer L Milucky, Lesley McGee, et al.
MMWR. Morbidity and Mortality Weekly Report
|
December 1, 2022
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022
Ruth Link-Gelles, Allison Avrich Ciesla, Katherine E Fleming-Dutra, et al.
MMWR. Morbidity and Mortality Weekly Report
|
February 16, 2023
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023
Katherine E Fleming-Dutra, Allison Avrich Ciesla, Lauren E Roper, et al.
Plos One
|
April 11, 2019
Surveillance for incidence and etiology of early-onset neonatal sepsis in Soweto, South Africa
Sithembiso C Velaphi, Matthew Westercamp, Malefu Moleleki, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
JAMA
|
February 14, 2022
Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance
Amadea Britton, Katherine E Fleming-Dutra, Nong Shang, et al.
Vaccine
|
July 2, 2022
Methodology for a correlate of protection for group B Streptococcus: Report from the Bill & Melinda Gates Foundation workshop held on 10 and 11 February 2021
Peter B Gilbert, Richard Isbrucker, Nick Andrews, et al.
JAMA Pediatrics
|
January 13, 2015
Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid
M Elsa Villarino, Nigel A Scott, Stephen E Weis, et al.
JAMA Internal Medicine
|
December 5, 2022
Association of Pneumococcal Conjugate Vaccine Use With Hospitalized Pneumonia in Medicare Beneficiaries 65 Years or Older With and Without Medical Conditions, 2014 to 2017
Miwako Kobayashi, Michael W Spiller, Xiyuan Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 7, 2007
Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays
Gerald H Mazurek, Margan J Zajdowicz, Arlene L Hankinson, et al.
Open Forum Infectious Diseases
|
May 22, 2023
Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods
Allison Avrich Ciesla, Ryan E Wiegand, Zachary R Smith, et al.
The Journal of Infectious Diseases
|
September 1, 2021
Nasopharyngeal Carriage of Streptococcus pneumoniae Among Young Children in Haiti Before Pneumococcal Conjugate Vaccine Introduction
Louise K Francois Watkins, Jennifer L Milucky, Lesley McGee, et al.
MMWR. Morbidity and Mortality Weekly Report
|
December 1, 2022
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022
Ruth Link-Gelles, Allison Avrich Ciesla, Katherine E Fleming-Dutra, et al.
MMWR. Morbidity and Mortality Weekly Report
|
February 16, 2023
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023
Katherine E Fleming-Dutra, Allison Avrich Ciesla, Lauren E Roper, et al.
Plos One
|
April 11, 2019
Surveillance for incidence and etiology of early-onset neonatal sepsis in Soweto, South Africa
Sithembiso C Velaphi, Matthew Westercamp, Malefu Moleleki, et al.
Page
of 5